Clinical Trial: A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06792695) titled 'A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer' on Jan. 20.

Brief Summary: The main purpose of this study is to evaluate the safety and efficacy of novel study interventions and combinations in participants with Colorectal Cancer (CRC).

Study Start Date: March 19

Study Type: INTERVENTIONAL

Condition: Metastatic Colorectal Cancer

Intervention: DRUG: Volrustomig

Volrustomig will be administered as intravenous (IV) infusion.

DRUG: FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan)

FOLFIRI will be administered as IV infusion.

DRUG: Bevacizumab

Bevacizumab will be administered a...